he anti-wrinkle drug Botox is unlikely to be recommended for the treatment of chronic migraines on the NHS in England and Wales, the medicines watchdog said.
The National Institute for Health and Clinical Excellence (NICE) has published draft guidelines saying there is insufficient evidence.
It wants the manufacturer, Allergan, to provide better data before making a final decision in June.
Thursday, February 16, 2012
BBC News - Not enough evidence for Botox migraine jab, says NICE